Flipping the standard doses of nivolumab plus ipilimumab for patients with advanced melanoma may improve survival with less toxicity, a real-world study finds.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/flipped-dose-immunotherapy-may-improve-melanoma-outcomes-2025a1000ysp?src=rss
Author :
Publish date : 2025-12-11 16:27:00
Copyright for syndicated content belongs to the linked Source.